Jackson W. Kiser, MD

home / authors / jackson-w-kiser-md

Articles

A study aimed to determine the variables that correlated with extravasation rates in patients receiving radiation injection therapy.

Modifying Radioactive Injection Techniques May Decrease Extravasation Rate

Jackson W. Kiser, MD
April 24th 2025

A study aimed to determine the variables that correlated with extravasation rates in patients receiving radiation injection therapy.

Extravasation with beta emitters may elicit more drastic adverse effects due to their higher radiation dose.

Radiologist Shares Procedures for Radioactive Injections, Extravasation

Jackson W. Kiser, MD
April 23rd 2025

Extravasation with beta emitters may elicit more drastic adverse effects due to their higher radiation dose.

Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.

Bill Seeks to Require Reporting of Extravasated Tissue in Radiology

Jackson W. Kiser, MD
April 19th 2025

Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.

Latest Updated Articles

Treosulfan plus fludarabine is now approved by the FDA as an injection for allo-HSCT conditioning for patients with AML or MDS.
Published: January 24th 2025 | Updated: February 6th 2025
FDA Approves Treosulfan Combo Injection for HSCT Conditioning in AML/MDS
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Liver Mass Found in 38-Year-Old Woman
Published: January 28th 2017 | Updated: April 25th 2025
Liver Mass Found in 38-Year-Old Woman